May 23, 2019
(Washington, D.C.) —Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott issued the following statement on draft legislation introduced by the U.S Senate Health Education, Labor and Pensions (HELP) Committee:
“We are still reviewing many of the provisions included in this draft legislative package. As a fundamental principle, pharmacy benefit managers (PBMs) believe that employer clients in the private sector should have choices in designing health benefits that ensure lower prescription drug costs and improved care coordination for the patients and enrollees that they represent.
PBMs support transparency for patients and their providers, our clients, and policymakers so they can make informed decisions that lead to optimal health outcomes and lower costs. Greater transparency among all players in the drug supply chain, including drug manufacturers and wholesalers, is an important step for understanding the root causes of high drug prices.
We look forward to working with the committee and appreciate the chance to review this important legislative initiative.”
PCMA is the national association representing America’s pharmacy benefit managers (PBMs). PBMs administer prescription drug plans for more than 266 million Americans who have health insurance from a variety of sponsors including: commercial health plans, self-insured employer plans, union plans, Medicare Part D plans, the Federal Employees Health Benefits Program (FEHBP), state government employee plans, Medicaid plans, and others.